Transcranial Magnetic Stimulators Market is boosted with rising prevalence of neurological disorders

Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation which uses magnetic induction forces focusing on a particular area of the brain. The electromagnetic induction is generated from a coil using electricity and these pulses travel through the cranium to its specified receptor area of the brain. Several different methods of brain stimulation are available including electroconvulsive therapy and deep brain stimulation techniques; however, currently, the transcranial magnetic stimulation technique is the most widely adopted method for brain stimulation. Transcranial magnetic stimulator devices consist of a coil and a system for analyzing and detection of the effects of the therapy. The coils used in TMS equipment are of different materials such as a coil made up of magnetically inert material (air-core design) or a magnetically active material (solid-core design), depending upon the variations and biophysical characteristics required.

Single or paired pulse TMS and repetitive TMS (rTMS) are the two types of transcranial magnetic stimulation techniques. The single or paired pulse TMS is currently the most widely adopted technique; however, promising results of the rTMS technique for treatment of various psychiatry disorders and rising clinical studies proving the efficiency of the technique are expected to drive the rTMS stimulators segment in the next few years. Applications of transcranial magnetic stimulators include research, diagnostics, and therapeutics. Diagnostic applications include evaluation of the effects of diseases such as stroke, multiple sclerosis, and other neurological diseases on the brain. Therapeutic applications of transcranial magnetic stimulators include treatment of treatment-resistant major depression, migraine, obsessive compulsive disorder (OCD), schizophrenia, and post-traumatic stress, among other psychiatry diseases. Various clinical trials are under way for the application of transcranial magnetic stimulation technique in the treatment and diagnosis of other major diseases affecting the brain.

Major factors expected to drive the transcranial magnetic stimulators market during the forecast period are rising prevalence of neurological disorders including schizophrenia and other disorders, surging geriatric population leading to increasing brain disorders associated with age, growing applications of the transcranial magnetic stimulation technique in diagnosis and treatment of neurological disorders, favorable reimbursements, and new and technologically advanced products introduced by manufacturers such as neuro-navigating stimulators in the global market. However, clinically proven high efficiency of electroconvulsive therapy in the treatment of psychotic depression and rising number of patients adopting the therapy is likely to be one of the major restraints of the transcranial magnetic stimulators market during the forecast period.

In terms of region, the global transcranial magnetic stimulators market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global transcranial magnetic stimulators market from 2017 to 2025, owing to factors such as a large patient population suffering from depression and other psychological and neurological disorders, growing number of devices receiving regulatory approvals, rising demand for new and advanced stimulators, and favorable reimbursement policies. According to Centers of Disease Control and Prevention (CDC) statistics, an estimated 3.5 million to 4 million people in the U.S. alone were suffering from treatment-resistant depression. There has been increasing collaborations and partnerships in the global market between companies and research universities for the advancement of the devices and technology along with widening the scope of applications of the transcranial magnetic stimulators. This along with increasing approvals present wide opportunities for the market players operating in the region. However, rising incidence of psychological disorders in Asia Pacific, increasing health care expenditure, and rising demand for new techniques for the treatment of these disorders are expected to augment the transcranial magnetic stimulators market in Asia Pacific from 2017 to 2025.

Key players operating in the global transcranial magnetic stimulators market include Axilum Robotics, Mastigm, Nexstim plc, Neuronetics, Inc., Brainsway Ltd., and TMS Neuro Solutions.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Source:
http://www.editiontruth.com/transcranial-magnetic-stimulators-market/

LFMS Treatment: How to Use LFMS Therapy to Treat Insomnia and Depression?

A few Treatments for Brain Stimulation:

Brain incitement medicines like electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) are frequently successful for the treatment of depression. For instance, a patient may get a few weeks of regular ECT treatments before a full response achieved. Consequently, there is a force to create stimulant medicines that acts quickly to improve the state of mind. It uses magnetic fields that are having a small amount of the strength but have higher frequency than the electromagnetic fields utilized in TMS and ECT. For sure, the potential stimulant properties of LFMS were found accidently, while specialists were directing an imaging study in healthy volunteers.

Utilization of Magnets in Magnetic Therapy:

One of the ways magnets and magnetic fields help the body is by expanding blood flow. That is really good news from people who experience the ill effects from insomnia since more blood in your cerebrum implies more relaxation and a better possibility of falling asleep and sleeping through the night. People have been utilizing magnets for treatment for 100s of years now; however the magnetic therapy for insomnia was out of range for some people. That is a result of the high cost of magnetic field products designed for enhanced sleep. Presently, with the recent advent of inexpensive blankets, mattress and bedding covers with small magnets sewn within them, thousands of people are getting help.

Comparing the Treatments by Experimenting on Patients:

At that point it is planned and constructed as a portable LFMS gadget that conveys a low-quality, high-frequency, electromagnetic field waveform to the cerebrum. An aggregate of 63 currently depressed patients, diagnosed to have either main depressive disorder or bipolar disorder. Those patients are participated in the study and were randomized to get a single 20-minute of genuine LFMS Treatment or sham LFMS, where the device was on however the electromagnetic fields were idle. Since neither the patients nor the analysts realized what treatment each person really got, the genuine impact of the LFMS could be measured.

Results of Comparison:

An immediate and significant improvement was seen in the patients who got genuine LFMS, compared with the individuals who got the sham treatment. There were no reported side effects. This finding recommends that LFMS may have the ability to provide instant relief of depressed state of mind, maybe even in emergency situations. It also confirms the achievement of the device’s design.